286 related articles for article (PubMed ID: 28284322)
1. A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study.
Kardos P; Vogelmeier C; Worth H; Buhl R; Lossi NS; Mailänder C; Criée CP
Respir Med; 2017 Mar; 124():57-64. PubMed ID: 28284322
[TBL] [Abstract][Full Text] [Related]
2. A year in the life of German patients with COPD: the DACCORD observational study.
Buhl R; Criée CP; Kardos P; Vogelmeier C; Lossi N; Mailänder C; Worth H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1639-46. PubMed ID: 27499620
[TBL] [Abstract][Full Text] [Related]
3. The 'real-life' COPD patient in Germany: The DACCORD study.
Worth H; Buhl R; Criée CP; Kardos P; Mailänder C; Vogelmeier C
Respir Med; 2016 Feb; 111():64-71. PubMed ID: 26775251
[TBL] [Abstract][Full Text] [Related]
4. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.
Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF
Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047
[TBL] [Abstract][Full Text] [Related]
5. COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study.
Kardos P; Vogelmeier CF; Worth H; Buhl R; Obermoser V; Criée CP
Lung; 2020 Jun; 198(3):507-514. PubMed ID: 32367415
[TBL] [Abstract][Full Text] [Related]
6. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
Vogelmeier C; Worth H; Buhl R; Criée CP; Lossi NS; Mailänder C; Kardos P
Int J Chron Obstruct Pulmon Dis; 2017; 12():487-494. PubMed ID: 28203072
[TBL] [Abstract][Full Text] [Related]
7. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
8. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
[TBL] [Abstract][Full Text] [Related]
9. Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study.
Buhl R; Criée CP; Kardos P; Vogelmeier CF; Kostikas K; Lossi NS; Worth H
Int J Chron Obstruct Pulmon Dis; 2018; 13():2557-2568. PubMed ID: 30197512
[TBL] [Abstract][Full Text] [Related]
10. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
[TBL] [Abstract][Full Text] [Related]
13. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
14. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
15. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
Melbye H; Al-Ani S; Spigt M
Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
[TBL] [Abstract][Full Text] [Related]
16. A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program.
Cushen B; McCormack N; Hennigan K; Sulaiman I; Costello RW; Deering B
Respir Med; 2016 Oct; 119():55-62. PubMed ID: 27692148
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for FEV
Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
[TBL] [Abstract][Full Text] [Related]
19. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of asthma-COPD overlap syndrome identified by a stepwise approach.
Inoue H; Nagase T; Morita S; Yoshida A; Jinnai T; Ichinose M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1803-1810. PubMed ID: 28694693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
